Table-1.
Proportions of AMR in clinical Avian E. coli isolates, obtained from South Africa in 2016.
| Variable | Percentage AMR | 95% CI | Percentage MDR | 95% CI | ||
|---|---|---|---|---|---|---|
|
|
|
|||||
| Lower | Upper | Lower | Upper | |||
| Drug compounds | ||||||
| Colistin sulfate | 0 (0/50) | 0.00 | 7.1 | 0 (0/22) | 0.00 | 15.4 |
| Ampicillin | 32 (16/50) | 19.5 | 46.7 | 68.2 (15/22) | 45.1 | 86.1 |
| Fosfomycin | 14 (7/50) | 5.8 | 26.7 | 27.3 (6/22) | 10.7 | 50.2 |
| Enrofloxacin | 32 (16/50) | 19.5 | 46.7 | 59.1 (13/22) | 36.4 | 79.3 |
| Doxycycline | 44 (22/50) | 30.0 | 58.7 | 77.3 (17/22) | 54.6 | 92.2 |
| Neomycin | 6 (3/50) | 1.3 | 16.5 | 13.6 (3/22) | 2.9 | 34.9 |
| Sulfamethoxazole/trimethoprim | 38 (19/50) | 24.7 | 52.8 | 63.6 (14/22) | 40.7 | 82.8 |
| Kanamycin | 8 (4/50) | 2.2 | 19.2 | 18.2 (4/22) | 5.2 | 40.3 |
| Ceftiofur | 10 (5/50) | 3.3 | 21.8 | 22.7 (5/22) | 7.8 | 45.4 |
| Cefoxitin | 20 (10/50) | 10.0 | 33.7 | 36.4 (8/22) | 17.2 | 59.3 |
| Provinces | ||||||
| Mpumalanga | 71.4 (5/7) | 29.0 | 96.3 | 22.7 (5/22) | 7.8 | 45.4 |
| Gauteng | 50 (10/20) | 27.2 | 72.8 | 31.8 (7/22) | 13.9 | 54.9 |
| North West | 82.6 (19/23) | 61.2 | 95.0 | 45.5 (10/22) | 24.4 | 67.8 |
AMR=Antimicrobial resistance, E. coli=Escherichia coli, MDR=Multiple drug-resistant